Cargando…

High Level of Serum and Cerebrospinal Fluid of Heparan Sulfate and Hyaluronic Acid Might Be a Biomarker of Severity of Neuromyelitis Optica

BACKGROUND: Neuromyelitis optica (NMO), multiple sclerosis (MS) and autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy are idiopathic inflammatory demyelinating diseases (IIDDs) that mainly present as encephalomyelitis. Heparan sulfate (HS) and hyaluronic acid (HA) are two components o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qi, Pei, Shanshan, Zhou, Zheyi, Wang, Zhanhang, Peng, Yu, Chen, Jinyu, Wang, Honghao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339917/ https://www.ncbi.nlm.nih.gov/pubmed/34367165 http://dx.doi.org/10.3389/fimmu.2021.705536

Ejemplares similares

Microglial/macrophage activation in the cerebrospinal fluid of neuromyelitis optica spectrum disorders
por: Li, Jinghong, et al.
Publicado: (2022)

The CSF Levels of Neutrophil‐Related Chemokines in Patients with Neuromyelitis Optica
por: Liu, Zhuhe, et al.
Publicado: (2020)

Elevated Levels of NLRP3 in Cerebrospinal Fluid of Patients With Autoimmune GFAP Astrocytopathy
por: Luo, Ying, et al.
Publicado: (2019)

Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients
por: Bai, Shumei, et al.
Publicado: (2009)

Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder
por: Yamashita, Kazuya, et al.
Publicado: (2018)

Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica
por: Guo, Yong, et al.
Publicado: (2017)

Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
por: Sato, Douglas Kazutoshi, et al.
Publicado: (2014)

Detection of mumps virus RNA in cerebrospinal fluid of patients with neuromyelitis optica
por: Mori, Masahiro, et al.
Publicado: (2011)

Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders
por: Shu, Yaqing, et al.
Publicado: (2016)

Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica
por: Kariya, Yoshinobu, et al.
Publicado: (2015)

Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid
por: Marignier, R., et al.
Publicado: (2016)

High Level of Soluble CD146 In Cerebrospinal Fluid Might be a Biomarker of Severity of Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Li, Qing, et al.
Publicado: (2021)

Cerebrospinal fluid light and heavy neurofilament level increased in anti‐N‐methyl‐d‐aspartate receptor encephalitis
por: Li, Jiayu, et al.
Publicado: (2019)

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance
por: Jarius, Sven, et al.
Publicado: (2010)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Elevated Serum and Cerebrospinal Fluid CD138 in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis
por: Zhu, Jiajia, et al.
Publicado: (2019)

Prospective evaluation of Chondroitin sulfate, Heparan sulfate and Hyaluronic acid in prostate cancer
por: da Silva, Matheus N. Ribeiro, et al.
Publicado: (2018)

Protein interactors of 3-O sulfated heparan sulfates in human MCI and age-matched control cerebrospinal fluid
por: Ferreira, Andreia, et al.
Publicado: (2023)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Anti-Mycobacterial Antibodies in Paired Cerebrospinal Fluid and Serum Samples from Japanese Patients with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder
por: Yokoyama, Kazumasa, et al.
Publicado: (2018)

Therapeutic Response and Possible Biomarkers in Acute Attacks of Neuromyelitis Optica Spectrum Disorders: A Prospective Observational Study
por: Wang, Jingqi, et al.
Publicado: (2021)

Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis
por: Matsushita, Takuya, et al.
Publicado: (2013)

Cytokines and chemokines expression in serum of patients with neuromyelitis optica
por: Ai, Nanping, et al.
Publicado: (2019)

Cerebrospinal Fluid Osteopontin and Inflammation-Associated Cytokines in Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Zou, Cong, et al.
Publicado: (2020)

The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013)

Neuromyelitis optica and neuroregeneration
Publicado: (2012)

Immunotherapy of Neuromyelitis Optica
por: Bienia, Benjamin, et al.
Publicado: (2013)

Increased Serum Hyaluronic Acid and Heparan Sulfate in Dengue Fever: Association with Plasma Leakage and Disease Severity
por: Tang, Tommy Hing-Cheung, et al.
Publicado: (2017)

Treatment strategies for neuromyelitis optica
por: Huang, Tzu-Lun, et al.
Publicado: (2018)

The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations
por: Kowarik, Markus C, et al.
Publicado: (2015)

Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report
por: Bejerot, Susanne, et al.
Publicado: (2019)

Heparan sulfates and heparan sulfate binding proteins in sepsis
por: Liao, Yi-En, et al.
Publicado: (2023)

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013)

Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico
por: Zarei, Sara, et al.
Publicado: (2018)

Different Phenotypes at Onset in Neuromyelitis Optica Spectrum Disorder Patients with Aquaporin-4 Autoimmunity
por: Long, Youming, et al.
Publicado: (2017)

Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica
por: Wang, Zhen, et al.
Publicado: (2017)

New Insights into Neuromyelitis Optica
por: Kim, Woojun, et al.
Publicado: (2011)

Experimental Models of Neuromyelitis Optica
por: Bradl, Monika, et al.
Publicado: (2013)

Molecular Pathogenesis of Neuromyelitis Optica
por: Bukhari, Wajih, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n3agrktt9ghm8butgvi9ftalu6